Page 219 - economic_survey_2021-2022
P. 219

Prices and Inflation  193




                   Rise in prices of Large Residential               Decline in prices of Large
                               Properties                              Residential properties
                   17,500                                        36,500
                   15,500                                        31,500
                   13,500                                        26,500
                  Rs Per Sq Ft  9,500                           Rs Per Sq Ft  21,500
                   11,500

                    7,500
                                                                 16,500
                    5,500
                    3,500                                        11,500
                    1,500                                         6,500
                            Jun-18  Sep-18  Dec-18  Mar-19  Jun-19  Sep-19  Dec-19  Mar-20  Jun-20  Sep-20  Dec-20  Mar-21  Jun-21  1,500


                          Ranchi          Gandhinagar                    Jun-18  Sep-18  Dec-18  Mar-19  Jun-19  Sep-19  Dec-19  Mar-20  Jun-20  Sep-20  Dec-20  Mar-21  Jun-21
                          Delhi           Noida                            Thane       Mumbai


             Source: NHB
             Note: Small size = [<=60 sq.mt.(646 sq.ft)]; Medium= [>60 sq.mt.(646 sq.ft) and <=110 sq.mt.(1184 sq.ft)]; Large
             properties (>110 sq.mt.(1184 sq.ft)).

             PHARMACEUTICAL PRICING

             5.39  Government regulates pricing of drugs to ensure availability and accessibility of medicines
             at affordable prices. National Pharmaceutical Pricing Authority (NPPA), an attached office of
             the Department of Pharmaceuticals (DoP), is mandated to regulate the prices of drugs.
             5.40  Several steps have been taken to ensure the affordability of drugs and medical devices.
             Ceiling prices for 355 medicines and 886 formulations were fixed for medicines under National
             List of Essential Medicines, 2015 (Schedule-I of Drug Price Control Order (DPCO), 2013) until
             31 December 2021. Retail prices for approximately 1798 formulations were fixed under DPCO,
             2013 till 31 December 2021. During the recent years, exercising extraordinary powers under
             DPCO, 2013 in public interest, prices of coronary stents and knee implants have also been fixed.
             NPPA also capped the trade margin up to 30 per cent on selected 42 anti-cancer non-schedule
             medicine on pilot basis in February, 2019.
             COVID-19 Initiatives:

             l   Based on recommendations of Standing Committee on Affordable Medicines and Health
                 Products (SCAMHP), NITI Aayog, NPPA capped the trade margin for Oxygen Concentrators
                 at 70 per cent on Price to Distributor (PTD) level on 3rd June 2021.
             l   Trade margins on Pulse Oximeter, Glucometer, Blood Pressure Monitor, Nebulizer  and
                 Digital Thermometer were also capped on July 13, 2021. As a result, most of the brands of
                 these devices have dropped prices up to 89 per cent.

             l   Most of drugs used for COVID management are scheduled drugs for which ceiling price has
                 been given by NPPA. Even in the case of a few non-scheduled medicines like Remdesivir,
   214   215   216   217   218   219   220   221   222   223   224